α,ω-双(4-(4′-甲基)-偶氮苯基)苯氧甲基-1,1,3,3-四甲基二硅氧烷的合成和结构

合成了（ＣＨ３（Ｃ６Ｈ４）Ｎ２（Ｃ６Ｈ４）ＯＣＨ２Ｓｉ（ＣＨ３）２２Ｏ,对其晶体结构及分子偶极矩进行了研究．结果表明,晶体属单斜晶系,Ｉ２Ａ空间群,晶胞参数如下：ａ＝２．１７８３４ｎｍ,ｂ＝０．８０３２５ｎｍ,ｃ＝２．０８８９５ｎｍ,β＝１１９．１９１°,Ｖ＝３１８２６ｎｍ３,Ｚ＝４,Ｄｃ＝１．２１６ｋｇ／ｍ３．分子偶极矩μ＝８．９３２×１０－３０Ｃ·ｍ．通过对分子结构和矩值的分析,说明了由刚性基团和柔性基团组成的端介晶基四甲基二硅氧烷的性能与结构之间的关系．     

1,3-二烯基-1,1,3,3-四甲基二硅氧烷/苯乙烯共聚物的合成及其热性能

有机硅聚合物具有柔软、耐热、耐水、抗生物污染等优点,若在聚合物中引入其它官能团,可进一步改善其性能,扩大应用领域,如:气体分离膜[1,2]、耐紫外线及X-射线材料[3]、半导体材料[4]、药物载体[5]、液晶材料[6]、阻燃材料[7]等.特别是含硅烷基苯乙烯衍生物系列的聚合物,其膜适用于氧等气体的分离,近来出现许多研究报道[1,2,8,9].     

1,3-二烯基-1,1,3,3-四甲基二硅氧烷/苯乙烯共聚合的环化率与竞聚率

对１３０℃下１，３ 二烯基 １，１，３，３ 四甲基二硅氧烷（ＤＶＤＳ）／苯乙烯（Ｓｔ）的溶液环化共聚合动力学进行了研究．根据低转化率（＜１０％）的共聚物组成及环状结构比例，通过参数估计方法，求得环化率与竞聚率，分别为ｒ１＝０１０２、ｒ２＝３４８、ｒｃ＝００２１０、Ｋｃ＝３８１ｍｏｌ／Ｌ、Ｋ′ｃ＝０３８９ｍｏｌ／Ｌ，同时得到它们９５％置信概率的联合置信区间及其交互影响的联合置信区间．表明ＤＶＤＳ的反应活性较Ｓｔ低，其非环状结构自由基具有较强的分子内环化反应能力；环的位阻效应使环状结构ＤＶＤＳ自由基的活性低于其非环状结构自由基．     

1,3-双(2-取代硫醚-1,3,4-噁二唑-5-基)苯的合成及其杀菌活性

以间苯二甲酸二甲酯为起始原料,经酰肼化、关环和硫醚化反应合成了8个新型的1,3-双(2-取代硫醚-1,3,4-噁二唑-5-基)苯,其结构经1H NMR,MS和元素分析表征。初步的生物活性测试结果表明,部分化合物具有较好的杀菌活性。     

1,3-双[3-(1-甲氧基-2-羟基丙氧基)丙基]封端聚硅氧烷的合成

以1,3-双[3-(1-甲氧基-2-羟基丙氧基)丙基]四甲基二硅氧烷和八甲基环四硅氧烷(D4)为原料,通过阳离子催化开环聚合制备了1,3-双(3-(1-甲氧基-2-羟基丙氧基)丙基)封端聚硅氧烷,研究了反应温度,反应时间,催化剂种类及加入量对于聚合反应的影响,结果表明,最佳反应条件为:反应温度65℃,反应时间24h,浓硫酸作为催化剂加入量为反应物质量的0.3%,此时反应拥有最高的转化率。通过红外光谱与核磁共振光谱对产物进行了表征。     

1,2-双(四甲基环戊二烯基)四甲基二硅烷与六碳基钼的反应

1,2-双(四甲基环戊二烯基)四甲基二硅烷与正丁基锂作用生成(四甲基二硅撑)双(四甲基环戊二烯基负离子盐),后者随即与六碳基钼反应形成1,1'-(四甲基二硅撑)双(四甲基环戊二烯基铝负离子盐)-(Me₂SiSiMe₂)[Me₄CpMo(CO)₃-Li⁺]₂(I),I与冰醋酸作用,随即分别与CCl₄,NBS及I₂反应,生成相应的铝卤化合物(Me₂SiSiMe₂)[Me₄CpMo(CO)₃X]₂[X=Cl(1),Br(2),I(3)].I与CH₃I反应,在钼原子上发生烃基化,得到产物(Me₂SiSiMe₂)[Me₄CpMo(CO)₃Me]₂(4);I与单质I₂直接反应,生成脱硅桥产物Me₄Cp(CO)>₃I(5).经元素分析、IR及¹HNMR表征了化合物1-5的结构。     

(四甲基二硅撑)二(3-三甲硅基环戊二烯基)四羰基二铁及其相关化合物的合成及结构

1,2-二(三甲硅基环戊二烯基)四甲基二硅烷与Fe(CO)5在二甲苯中于105～110℃反应除分离到少量标题化合物(Me2SiSiMe2)[η-(3-Me3SiC5H3Fe(CO)]2(μ-CO)2(5)外,主要是生成了脱Me3Si基的产物(Me2SiSiMe2)[η-C5H4Fe(CO)]2(μ-CO)2(1)及1的热重排异构体[Me2SiC5H4-Fe(CO)2]2(2).将5的二甲苯溶液加热回流18h,则转化为其异构体[Me2Si(Me3SiC5H3)Fe(CO)2]2(6).脱硅基发生在由相应反应物制备5的过程中。且脱硅基是与反应物中(Me2SiSiMe2)桥的存在有关。5的晶体结构经X射线衍射测定属单斜晶系,P21/m空间群,晶体学数据:a=0.6780(1)nm,b=2.2303(9)nm,c=0.9988(1)nn,;β=98.96(1)°,V=1.4960nm3.Z=2,Dc=1.36g/cm3.     

新型2-(2'-取代亚肼基)-1,3-二硫杂环戊烷衍生物的合成和菌活性研究

通过结构改造并结合活性基团的拼接合成了11个未见文献报道的新型2-(2'-取代亚肼基)-1,3-二硫杂环戊烷类化合物, 所有的目标物的结构都经¹H NMR, MS, IR和元素分析证实, 选择了其中5个化合物对7种细菌进行了抑菌活性测试, 并与市售农药20%三环唑、70%威尔达甲托的抑菌活性进行对比, 发现它们比市售农药有更为广泛的杀菌谱, 对照农药只对金黄色葡萄球菌有良好的抑菌作用而这些化合物则对所选择的七个菌种均有良好的抑菌作用. 其中化合物2-(对氟苯氧乙酰亚肼基)-1,3-二硫杂环戊烷(4c)的杀菌谱很广, 它对金色葡萄球菌、大肠杆菌、白色念珠菌的抑杀活性都很好.     

2-(2-喹啉偶氮)-5-二甲氨基酚分光光度法测定钒

研究了新试剂2 (2 喹啉偶氮) 5 二甲氨基酚(QADMAP)与钒的显色反应,在pH3.5的柠檬酸 NaOH缓冲介质中,溴化十六烷基三甲基胺(CTMAB)存在下,QADMAP与钒反应生成2∶1稳定络合物,络合物最大吸收波长为580nm,摩尔吸光系数ε=1 12×105L·mol-1·cm-1,钒质量浓度在0～0 6μg mL内符合比尔定律。方法已用于几种合金样品中钒的分析。     

Synthesis, Crystal Structure and Antitumor Activity of 4-tert-Butyl-N-（2-fluorophenyl）-5- （1H-1,2,4-triazol-1-yl）-thiazol-2-amine

The title compound has been synthesized by the reaction of 1-bromo-3,3-dime- thyl-1- (1H-1,2,4-triazol-1-yl)butan-2-one with 1-(2-fluorophenyl)thiourea, and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to the orthorhombic system, space group Pbca with a=15.2568(6), b=12.1533(5), c=16.7307(7) , Z=8, V=3102.2(2)3, Mr=317.39, Dc=1.359 g/cm3, S=1.05, μ=0.223 mm-1, F(000)=1328, the final R=0.034 and wR=0.097 for 2590 observed reflections (I>2σ(I)). X-ray crystal structure presents the intramolecular N-H…N hydrogen bond, which plays an important role in stabilizing the crystal structure. In addition, the preliminary biological test on the title compound shows good antitumor activity, with IC50 of 0.122 μmol/mL against the Hela cell line.     

Synthesis and Crystal Structure of N-(Biphenyl-2-thiocarbamoyl)-4-(1,3-dichlorophenyl) Carboxamide

The synthesis of the title molecule was achieved by the reaction of 2,4-dichlorobenzoyl chloride with potassium thiocyanate in 1:1 molar ratio in dry acetonitrile to afford the corresponding isothiocyante in situ followed by the treatment with 2-aminobiphenyl. The structure of the target compound was established by elemental analysis, FTIR, 1H, 13 C NMR and mass spectroscopy and unequivocally confirmed by the crystallographic data. The title compound crystallizes in the monoclinic space group P21/n with a = 13.356(2), b = 7.0761(11), c = 20.539(3) , β = 105.723(4)°, V = 1868.5(5) 3 and Z = 4.     

Synthesis, Crystal Structure and Antibacterial Activities of 3-[3-Methyl-（2-thienyl）methyl-enehydrazinocarbonyl]-（1H）-1,2,4-triazole

1 INTRODUCTION Azole derivatives, such as the derivatives of pyra- zole, imidazole, triazole including benzotriazole, te- trazole and indole, have extensive biological activi- ties. They have become the central focus of studies of agricultural chemicals, medicines, plant growth regulating agents and so on[1, 2]. Schiff bases also constitute a good type of biologically active sub- structures. Studies on pyrazole Schiff base-type fun- gicides have been reported[3, 4]. However, some struc- …     

Synthesis and Crystal Structure of 4-tert-Butyl-6-（4-chlorophenyl）-3,6- dihydro-2H-1,3-thiazin-2-iminium Chloride

The title compound, 4-tert-butyl-6-（4-chlorophenyl）-3,6-dihydro-2H-1,3-thiazin- 2-iminium chloride （C14H18C12N2S）, has been synthesized by the reaction of 1-（4-chlorophenyl）- 4,4-dimethylpent-1-en-3-one with thiourea, and its crystal structure was determined by single- crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group P211c with a = 16.3064（11）, b = 9.4471（6）, c = 11.2626 （8）A, β = 108.400（1）°, Z = 4, V = 1646.28（19） A^3, Mr = 317.26, Dc = 1.280 g/cm^3, S = 1.078,μ = 0.510 mm^-1, F（000） = 664, the final R = 0.0514 and wR = 0.1412 for 3210 observed reflections （I 〉 2σ（I））. The thiazine ring system displays a twisted boat conformation, and three N-H,..Cl hydrogen bonds exist in the crystal. The combination of two N-H...Cl hydrogen bonds generate an R2^1 （6） ring.     

Synthesis and Crystal Structure of （Z）-1- （3-Fluorobenzyl）-5-（（3-fluorobenzylimino）（2-hydroxy-4-methoxyphenyl）methyl）pyridin-2（1H）-one

The title compound （Z）-1-（3-fluorobenzyl）-5-（（3-fluorobenzylimino）（2-hydroxy-4- methoxyphenyl）methyl）pyridin-2（1H）-one （C27H22F2N2O3,Mr = 460.47） was synthesized and crystallized. The crystal belongs to the triclinic system,space group P1 with a = 9.951（6）,b = 10.059（6）,c = 12.927（7）A,α = 109.828（7）,β = 102.304（7）,γ = 104.898（7）°,Z = 2,V = 1110.2（11）A^3,Dc =1.377 Mg/m^3,μ（MoKα） = 0.102 mm^-1,F（000） = 480,the final R = 0.0449 and Rw = 0.1250 for 4595 observed reflections （I 〉 2σ（I））. X-ray analysis reveals that both m-fluorobenzyl groups are diorientationally disordered because of the rotation of C–C single bond which was represented as F（1）,F（2） and F（1＇）,F（2＇）. The diorientational disorder was refined and gave the occupancies of 0.665（4） and 0.335（4） for F（1） and F（1＇）,0.631（3） and 0.369（3） for F（2） and F（2＇）. Hydrogen bonds existing in the cell link different components to stabilize the crystal structure. The active data proved that the title compound has good anti-HBV activity.     

Synthesis,Crystal Structure and Antitumor Activity of 2-(3-Methyl-5-(methylthio)-4H-1,2,4-triazol-4-yl)isoindoline-1,3-dione

The title compound 2-(3-methyl-5-(methylthio)-4H-1,2,4-triazol-4-yl)isoindoline-1,3-dione(C12H10N4O2S, Mr = 274.30) has been synthesized by a three-step procedure including the cyclization, hydrazinolysis and substitution reactions, and its crystal structure was determined by X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group P21/c with a = 12.264(3), b = 14.646(3), c = 14.349(4) , β = 91.69(3)°, μ = 0.255 mm-1, Mr = 274.30, V = 2576.2(10) 3, Z = 8, Dc = 1.414 g/cm3, F(000) = 1136, R = 0.0487 and w R = 0.1329 for 4048 observed reflections with Ⅰ 2σ(Ⅰ). In addition, the preliminary bioassay suggested that the title compound 6 exhibits relatively good antitumor activity against HT-29 and MCF-7.     

Synthesis,Crystal Structure and Antitumor Activity of 4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)-N-(2-hydroxy-3,5-diiodinebenzyl)-thiazol-2-amine

The title compound, 4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)-N-(2-hydroxy-3,5-diiodinebenzyl)thiazol-2-amine, was synthesized via the reduction of 4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)-N-benzylidene-thiazol-2-amine with Na BH4, and its crystal structure was determined by single-crystal X-ray diffraction. The compound crystallizes in monoclinic system, space group P21/c with a = 7.91944(19), b = 10.5250(3), c = 24.4985(6) , Z = 4, V = 2041.66(9) 3, Mr = 599.22, Dc = 1.949 Mg/m3, S = 1.120, μ = 3.203 mm-1, F(000) = 1152, the final R = 0.0283 and wR = 0.0592 for 3490 observed reflections(Ⅰ 2σ(Ⅰ)). X-ray analysis displays that the crystal water takes part in three intermolecular hydrogen bonds of O(2)–H(2A)···O(1), O(2)–H(2B)···N(1) and N(5)–H(5)···O(2), and an octatomic ring is formed via intramolecular hydrogen bond of O(1)–H(1A)···N(4). Furthermore, the Ⅰ···Ⅰ contacts are involved in stabilizing the overall three-dimensional network structure. The preliminary biological test shows the title compound has good antitumor activity with the IC50 value of 26 μM against the Hela cell line.     

Synthesis and Crystal Structure of N,N′-Bis-[3-chloro-5-S-(l-menthyloxy)-2(5H)-4-furanon-yl]-propane-1,3-diamine

The title compound,N,N′-bis-[3-chloro-5-S-(l-menthyloxy)-2(5H)-4-furanon-yl]-propane-1,3-diamine(C31H48Cl2N2O6,Mr = 615.61),has been synthesized and characterized by IR,1H NMR,MS,elemental analysis and single-crystal X-ray diffraction.The crystal crystallizes in the monoclinic system,space group C2 with a = 16.1091(4),b = 11.1880(3),c = 19.2854(5) ,β = 106.297(2)°,V = 3336.12(15) 3,Z = 4,Dc = 1.226 mg/m3,μ = 0.237 mm-1,F(000) = 1320,the final R = 0.0531 and wR = 0.0700 for 2760 observed reflections(I > 2σ(I)).X-ray analysis reveals that the title compound possesses four rings:two chiral five-membered furanone rings and two six-membered cyclohexane rings with chair conformation,containing eight chiral centers:C2(S),C3(R),C5(R),C10(S),C18(S),C21(R),C22(S) and C25(R).The structure is stabilized by N-H…O hydrogen bonding interaction.     

Synthesis, Crystal Structure and Antibacterial Activities of 3-[（2-Hydroxy-4-diethylamino-phenyl）methylenehydrazinocarbonyl]-4-hydroxy-6-methyl-2（1H）-pyridinones

1 INTRODUCTION Recently, compounds containing pyrazole, imida- zole, triazole (including benzotriazole), pyridine, tetrazole and indole have attracted much interest because of their fungicidal activity, plant-growth regulating activity and antibacterial activity[1～3]. Schiff bases also constitute a good type of biolo- gically active substructures[4～7]. Studies of pyri- dine Schiff base-type fungicides have been repor- ted[8]. However, some structures of pyridine com- pounds containing h…     

Synthesis and Crystal Structure of Tert-butyl 4-[(E)-4-(1,3 -Dioxo-1,3-dihydro-2H-isoindol-2-yl)-1-butenyl] Benzoate

1 INTRODUCTION Phthalimide and its derivatives are synthetic mate- rials, which are widely used as important chemical intermediates of biosensors[1] and many drugs such as Citalopran[2], luminal[3], Beta-Lactam[4] and the No. three generation quinolones[5], and they have been identified as active groups of some drugs and chemical luminescence reagents[6, 7]. Tert-butyl 4- [(E)-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1- butenyl] benzoate is an intermediate of a new type of insulin sen…